The incidence of venous thromboembolism and major bleeding is high among patients with primary central nervous system lymphoma.
Findings from the study showed 44% of patients treated with berubicin experienced a statistically significant improvement in progression free survival.
Treatment disparities may explain worse outcomes for pediatric black and Hispanic brain cancer patients.
In the era of increasing survival of cancer patients, there are also changes in the presentation and outcomes of patients with pituitary metastasis.
The application is supported by data from 2 pivotal open-label, randomized phase 3 trials (SIOPEL 6 and ACCL0431), which compared the efficacy of sodium thiosulfate plus cisplatin to cisplatin alone for the prevention of cisplatin-induced hearing loss.
Death anxiety is common in patients with metastatic cancer, including those with metastatic non-small cell lung carcinoma.
An open-source smartphone and web application has been developed to help predict clinical malignancy and survival outcomes for meningioma.
Maximal resection of a contrast-enhanced (CE) tumor is associated with improved overall survival in patients with isocitrate dehydrogenase gene 1 or 2 (IDH)-wild-type and IDH-mutant subtype glioblastomas.
A novel workflow that combines advanced optical imaging with an artificial intelligence algorithm may accurately diagnose brain tumors in real time in the operating room.
The Food and Drug Administration (FDA) has granted Orphan Drug Designation to zotiraciclib (Adastra Pharmaceuticals) for the treatment of glioma.